Statistics published in 2014, showed that the number of obese and overweight individuals jumped from 857 million in 1980 to 2.1 billion in 2013…
This means that almost a third of the world is now dangerously overweight and obesity is a global health crisis that is not going away.
Obesity: Risky business
According to the US Centres for Disease Control, 25 per cent of the adult population is obese, in the UK. In the US, more than one third of the US population is obese and in Australia, 28 per cent of men and 30 per cent of women have weight problems.
Let’s face it, the mainstream’s attempts – ranging from getting fast food manufacturers to provide dietary guidelines (I kid you not!) to risky gastric bypass surgery – simply have had no impact on the planet’s expanding waistlines.
And if they were hoping that their latest hunger-curbing device will make a difference in the battle against the bulge, they’d better think again.
The “Maestro Rechargeable System” is an electrical “pulse” generator (like a pacemaker) that’s surgically implanted in your belly. Its job is to block signals from a nerve pathway to your brain and then to trick your brain into thinking you’re not hungry. It does that by manipulating your vagus nerve.
The vagus nerve, also called the “wandering” nerve, stretches all the way from your abdomen, through you heart, oesophagus and lungs, and ends up in your brain stem.
Maestro gives that vagus nerve ‘high frequency bursts’ of power – basically short-circuiting it with an electric current. All day. Every day.
What could possibly go wrong with that?
Well, nothing – if you believe the FDA’s survey.
That’s right, a survey.
It was the FDA’s first ever survey to figure out “patient risk tolerance.”
In other words, how much risk – like the “probability of death” – will the average patient accept in exchange for whatever benefit this device might deliver?
Of course, a measly survey can barely predict the real risks of this device. The FDA already knows that it causes pain where it’s inserted, as well as problems swallowing, nausea and chest pain… and surgical complications.
Then there’s also the fact that during its trial, the Maestro didn’t even meet its “endpoint” – the goal set to show if a drug or device actually works – but not to worry! The FDA’s advisory committee said that Maestro’s benefits still outweighed its risks.
In the meantime the manufacturer, EnteroMedics, has been told to follow a minimum of 100 Maestro guinea pigs for the next five years, to find out if they really lose weight – and of course what side effects might turn up.
Frankly, it’s horrifying to think people will submit themselves to this level of experimentation.
What’s even worse is that medical authorities are so blindsided in their attempts to make some progress in their battle against obesity that they would rubber-stamp devices like this without having any idea of their long-term complications.
However, the most ridiculous thing is that the CEO of EnteroMedics called the FDA’s approval of Maestro a “transformational event” for obese people.
No it’s not.
Inserting a device into your stomach that sends electrical currents through one of the key nerves in your heart and brain centre, is like swallowing a ticking time bomb… I’m sure that’s not the ‘transformation’ obesity patients had in mind.
Did you find this information useful?
"It is truly refreshing to read a newsletter on the topic of alternative medicine which is scientifically based and reviewed by professionals..." - Robert Sinott
Bear in mind all the material in this email alert is provided for information purposes only. We are not addressing anyone’s personal situation. Please consult with your own physician before acting on any recommendations contained herein.
“FDA clears ‘pacemaker for the stomach'” Thomas M. Burton, January 14, 2015, The Wall Street Journal, wsj.com
Government attacked over deals with fast-food industry: Pure illusion to think this approach can cut obesity, published online 03.02.14, independent.co.uk
Obesity Rates Increasing Worldwide, Crosses 2 Billion Mark, published online 29.05.14, hngn.com